Tue, Sep 2, 2014, 9:15 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • biotechbeagle biotechbeagle Dec 27, 2012 1:39 PM Flag

    OT AVEO

    AVEO very risky given TIVO phase III results. Doesn't look to be superior to ONXX drug. The chart looks good as its coming off of a double bottom. I'd sell it as it gets closer to PDUFA.

    IMGN on the other hand looks like it really wants to run higher except for Harry Reid driving market down today. After cliff resolved, this is going to run up to FDA review and if approved will retest high of $18.

    Sentiment: Strong Buy

 
IMGN
12.20+0.38(+3.21%)Sep 2 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.